CAVA just dropped ~10% after earnings on slowing same‑store sales and lowered guidance — despite beating on EPS and revenue. Is this a real opportunity or a classic falling knife? I break down the narrative, run a quick DCF vs PEG, and share my buy zones.

What happened: EPS/rev beat, but growth narrative cracked on SSS slowdown and guidance trim.

Numbers that matter: 398 stores, ~$954.3M TTM revenue, margin context, and why a 3% SSS delta can hit operating earnings double‑digits.

Valuation check: DCF base vs narrative case ($56.89 → ~$47.22), PEG cross‑check (~$58.75), current price context (~$84.50).

Buy levels I’m watching and what would change my mind.

Risk lens: What could go right (traffic/mix/unit growth) vs wrong (promo intensity, cost creep, comp deceleration).

This is not financial advice. Do your own research.

Hashtags: #CAVA #CAVAStock #Earnings #StockMarket #Investing #DCF #RestaurantStocks

Cardinal Health (CAH) just dropped over 7% after Q4 FY2025 results and a $1.9B Solaris Health acquisition. Is this a falling knife… or a setup for a smarter entry? In this episode, we break down the revenue miss, thin 3.53% gross margins, financing risk, DCF and PEG valuations, and my buy levels based on a net −6.5% near-term earnings impact.

Key points:

EPS/guidance up, but revenue miss + deal financing weigh on near-term earnings.

Thin gross margins amplify small revenue misses.

Staggered buy levels for better margin of safety.

If you found this useful, drop a like, comment your take on CAH’s Solaris deal, and subscribe for weekly “falling knife” breakdowns.

#stocks #CAH #CardinalHealth #stockmarket #earnings #valuation #DCF #investing #healthcare

Disclaimer: This video is for informational and entertainment purposes only and is not financial advice. Do your own research and consult a qualified advisor before investing.

When a stock drops 38.7% in days after beating earnings and raising guidance… you have to ask: did the story break, or did expectations snap? In this episode of “Am I Catching a Falling Knife?”, we dig into monday.com (MNDY): what they actually do, why Q3 “conservative” outlook spooked the Street, how 90% gross margins amplify narrative shocks, and what a 7.5% near-term earnings reset means for valuation. We run two lenses—DCF and PEG—then share clean buy levels for high-volatility hunters.

Key takeaways

Earnings paradox: Beat revenue/EPS and raised FY guide, but Q3 tone reset near-term growth expectations.

Margin amplifier: 90% gross margins mean small revenue slows can punch earnings hard.

Valuation range: DCF and PEG both compress fair value after a ~7.5% expectations haircut.

Game plan: Let price come to you

Important: This is not financial advice. Do your own research and consider your risk tolerance.

If you like data-driven breakdowns without the fluff, hit subscribe and drop your tickers for the next “falling knife” autopsy.

#Stocks #MNDY #mondaycom #Investing #Earnings #SaaS #DCF #PEG #StockMarket

Is Lululemon (LULU) stock in freefall—or is this the perfect time to buy the dip? In this episode of Am I Catching a Falling Knife?, Dave breaks down the recent 13.92% drop in LULU’s share price and dives deep into the numbers behind the headlines. From softening U.S. consumer spending to tariff impacts, we quantify the narrative and estimate a potential -10.4% hit to quarterly earnings. Using DCF and PEG models, we explore LULU’s true valuation and share custom buy levels for investors watching this volatile stock.

📉 Topics Covered:

LULU’s business breakdown

Revenue and margin impact analysis

Operating leverage explained

DCF vs PEG valuation

⚠️ Not financial advice. Always do your own research.

🔔 Subscribe for more satirical yet data-rich stock breakdowns

Under Armour (UA) just dropped 23.45%. Are we catching a falling knife or a rare value setup? In this episode, we break down the narrative (North America weakness, weak guidance, downgrades), quantify the hit (estimated 15% quarterly earnings decline via operating leverage), and stack valuations: DCF base ≈ $5.19 vs narrative case ≈ $4.15 and PEG-implied ≈ $4.46. We also map buy zones at $4.40, $4.00, and $2.50 for a cleaner margin of safety.Like/subscribe if you want more “Am I Catching a Falling Knife?” deep dives. Comment: Bargain or bust?Disclaimer: This video is for entertainment and information only, not financial advice. Do your own research and consult a qualified advisor.#UnderArmour #UA #Stocks #ValueInvesting #DCF #PEG #Earnings #RetailStocks #Athleisure #StockMarket

🎯 Title

TTD Stock CRASHED 37% — Is This a Buy or a Total Trap? | Falling Knife Analysis

📝 Description

Is The Trade Desk (TTD) a discounted gem or a financial disaster waiting to happen? In this episode of Am I Catching a Falling Knife?, we dissect TTD’s brutal 37% drop, break down the Q2 earnings drama, and run the numbers on valuation, margins, and operating leverage. With high fixed costs and slowing growth, is this a classic falling knife or a rare buying opportunity?

📉 Topics Covered:

Why TTD dropped 37% in days

Q2 earnings breakdown & cautious Q3 guidance

Revenue, margins, and operating leverage explained

DCF valuation

Custom buy levels

PEG ratio fail: What happens when growth turns negative?

⚠️ Not financial advice. Always do your own research.

🔔 Subscribe for more satirical deep dives into meme stocks, market meltdowns, and financial chaos.

#stockanalysis #stockmarket #stockcrash

Fortinet (FTNT) just tanked 28% — but is this cybersecurity giant a hidden gem or a value trap? In this episode of Am I Catching a Falling Knife?, Dave breaks down the real reasons behind the drop: slowing service revenue, SASE cannibalization fears, and analyst downgrades. We run the numbers with DCF and PEG models to reveal Fortinet’s true value — and share custom buy levels for risk-savvy investors.🔔 Subscribe for more deep dives into meme stocks, market meltdowns, and misunderstood opportunities.#stockanalysis #stockmarket #stockcrash

Eli Lilly (LLY) just dropped over 20% — but is it panic or opportunity? In this episode of Am I Catching a Falling Knife?, we dissect the GLP-1 drama, break down the earnings impact, and run valuation models to see if this pharma giant is oversold or overhyped.

🔍 Topics covered:

What happened with orforglipron

How investor sentiment affects earnings

DCF vs PEG valuation breakdown

📉 Not financial advice — just sharp analysis with a satirical edge.

Subscribe for more breakdowns of market meltdowns and meme stock madness.

#stockanalysis #stockmarket #stockcrash

Is Airbnb (ABNB) a screaming buy—or a classic falling knife? In this episode of Am I Catching a Falling Knife?, Dave breaks down the recent dip in Airbnb’s stock price and uncovers the real story behind the cautious outlook, margin pressures, and valuation disconnect.

🔍 What you'll learn:

Why Airbnb’s strong Q2 earnings aren’t saving the stock

How increased investments could slash profits by 20%

👉 Is this a dip worth buying—or a blade worth dodging? Tune in and decide.

🔔 Subscribe for more sharp takes on volatile stocks and market psychology.

#stockanalysis #stockcrash #airbnb

Is The Mosaic Company (MOS) a hidden gem or a financial landmine? In this episode of Am I Catching a Falling Knife?, we dissect MOS’s brutal 16.81% drop following its Q2 2025 earnings miss. We break down:What Mosaic actually does (hint: it’s all about crop nutrients)Why Wall Street got it wrongHow future earnings could take a 6% hitOur DCF and PEG-based valuationsCustom buy levels for brave investorsThis isn’t financial advice—it’s financial entertainment. Subscribe for more satirical deep dives into the wild world of meme stocks and market chaos.#MOS #StockCrash #FallingKnife #FinancePodcast #EarningsMiss #ValueInvesting #MemeStocks